These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 725923)

  • 21. Effects of psychodysleptics on aggressive behavior of animals.
    Uyeno ET
    Mod Probl Pharmacopsychiatry; 1978; 13():103-13. PubMed ID: 415228
    [No Abstract]   [Full Text] [Related]  

  • 22. A relationship between the hallucinogenic activity of drugs and their electronic configuration.
    Snyder SH; Merril CR
    Proc Natl Acad Sci U S A; 1965 Jul; 54(1):258-66. PubMed ID: 5216361
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of isolation-induced attack behavior of mice by drugs.
    Uyeno ET
    J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276
    [No Abstract]   [Full Text] [Related]  

  • 24. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB; Hine B; Gershon S
    Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
    [No Abstract]   [Full Text] [Related]  

  • 25. Behavioural effects of some morphine antagonists and hallucinogens in the rat.
    Schneider C
    Nature; 1968 Nov; 220(5167):586-7. PubMed ID: 5686733
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacological action spectra of hallucinogens].
    Waser PG
    Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts.
    Kleinman JE; Gillin JC; Wyatt RJ
    Schizophr Bull; 1977; 3(4):560-86. PubMed ID: 271353
    [No Abstract]   [Full Text] [Related]  

  • 28. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further investigation of the discriminative stimulus properties of MDA.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 1984 Apr; 20(4):501-5. PubMed ID: 6728867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.
    Nielsen EB; Lee TH; Ellison G
    Psychopharmacology (Berl); 1980; 68(2):197-200. PubMed ID: 6776566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
    Kovar KA
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reticular multiple unit activity during a progression of states induced by CNS excitants. 3.
    Winters WD; Mori K; Wallach MB; Marcus RJ; Spooner CE
    Electroencephalogr Clin Neurophysiol; 1969 Nov; 27(5):514-22. PubMed ID: 4187037
    [No Abstract]   [Full Text] [Related]  

  • 34. An animal behavior model for decreased central serotonergic function.
    Jacobs BL; Trulson ME
    Adv Exp Med Biol; 1981; 133():657-80. PubMed ID: 7315613
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats.
    Domino EF; Bartolini A
    Neuropharmacology; 1972 Sep; 11(5):703-13. PubMed ID: 4670597
    [No Abstract]   [Full Text] [Related]  

  • 36. Hallucinogenic drugs and circadian rhythms.
    Davies JA; Ancill RJ; Redfern PH
    Prog Brain Res; 1972; 36():79-95. PubMed ID: 4644034
    [No Abstract]   [Full Text] [Related]  

  • 37. Tolerance and cross-tolerance among psychotomimetic drugs.
    Appel JB; Freedman DX
    Psychopharmacologia; 1968 Sep; 13(3):267-74. PubMed ID: 5679628
    [No Abstract]   [Full Text] [Related]  

  • 38. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [USE OF PSYCHOTROPIC DRUGS IN PSYCHOTHERAPY].
    STEVENIN L; BENOIT JC
    Acta Psychother Psychosom; 1964; 12():168-87. PubMed ID: 14162290
    [No Abstract]   [Full Text] [Related]  

  • 40. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
    LUDWIG AM; LEVINE J
    JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.